Search results
Richard B. Silverman is a professor of chemistry and molecular biosciences at Northwestern University. He studies the design, synthesis, and mechanisms of action of potential medicinal agents for central nervous system disorders and cancer.
Richard Bruce Silverman (born May 12, 1946) is the Patrick G. Ryan/Aon Professor of Chemistry at Northwestern University. His group's main focus is basic and translational research into central nervous system disorders and cancer.
May 26, 2022 · Silverman, a Northwestern University professor, developed the drug Lyrica for neuropathic pain and epilepsy, but lost control of its clinical development to Pfizer. Now, he is leading Akava Therapeutics, a Chicago-based startup that aims to treat ALS and other neurological diseases with his discoveries.
Professor Richard B. Silverman is the inaugural Patrick G. Ryan/Aon Professor. Over the last 42 years at Northwestern University he has developed numerous projects related to the synthesis and evaluation of a variety of enzyme inhibitors and activators, particularly related to neurodegenerative and neurological diseases and cancer.
Richard B. Silverman is a Northwestern professor who discovered the molecule that became Lyrica, a blockbuster drug for epilepsy, neuropathic pain and fibromyalgia. Learn how his fundamental science led to a successful pharmaceutical product and a new research hub at Northwestern.
Oct 10, 2023 · Professor Richard B. Silverman of Northwestern University is the recipient of the 2024 Abeles and Jencks Award for the Chemistry of Biological Processes.
May 5, 2023 · Professor Richard B. Silverman, of the Department of Chemistry, was elected to the National Academy of Sciences (NAS), according to the Academy’s announcement on May 2nd. Silverman is the Patrick G. Ryan/Aon Professor at Northwestern.
